{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04581",
    "Peptide Name": "L-K6 I1W (T-1CEb analog, synthetic AMPs20a, Lys-rich, UCLL1)",
    "Source": "amino acid substitution, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "WKKILSKIKKLLK",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Synergistic AMPs"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 0.75,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "46%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (64.29%) toP5-CT3K: 46%, L: 23%.Activity: active against Gram+ S. aureus (MIC 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. aeruginosa including resistant MRPA0108 persisters (MIC 3.13-6.25 uM), K. pneumoniae (MIC 25 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 6.25 uM).MOA:bacteria:P. aeruginosa: permeate and depolarize bacterial membranes. ROS production as well (Li et al., 2024).Structure:  random coil in water and helical in SDS micelles or 50% TFE.In vitro toxicity: human RBC, HC50 >500 uM (not hemo.lytic).Synergy:antibiotics: FICI 0.3125 with tobramycin.",
    "Author": "Bi X, Wang C, Ma L, Sun Y, Shang D. 2013",
    "Reference": "J Appl Microbiol. 2013 Sep;115(3):663-72. doi: 10.1111/jam.12262.PubMed",
    "Title": "Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action."
  },
  "3D Structure": []
}